fluoxetine has been researched along with Cognitive Dysfunction in 10 studies
Fluoxetine: The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants.
fluoxetine : A racemate comprising equimolar amounts of (R)- and (S)-fluoxetine. A selective serotonin reuptake inhibitor (SSRI), it is used (generally as the hydrochloride salt) for the treatment of depression (and the depressive phase of bipolar disorder), bullimia nervosa, and obsessive-compulsive disorder.
N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine : An aromatic ether consisting of 4-trifluoromethylphenol in which the hydrogen of the phenolic hydroxy group is replaced by a 3-(methylamino)-1-phenylpropyl group.
Cognitive Dysfunction: Diminished or impaired mental and/or intellectual function.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The aim of the study is to verify whether LAC can have an antidepressant action in a population of elderly patients with dysthymic disorder in comparison with a traditional antidepressant such as fluoxetine." | 9.17 | L-Acetylcarnitine in dysthymic disorder in elderly patients: a double-blind, multicenter, controlled randomized study vs. fluoxetine. ( Bersani, FS; Bersani, G; Colletti, C; Denaro, A; Koverech, A; Liberati, D; Meco, G; Nicolai, R, 2013) |
| "Radiation therapy and concomitant temozolomide chemotherapy are commonly used in treatment of brain tumors, but they may also result in behavioral impairments such as anxiety and cognitive deficit." | 7.91 | Fluoxetine reverses brain radiation and temozolomide-induced anxiety and spatial learning and memory defect in mice. ( Chai, D; Gan, H; Wu, S; Zhang, Q; Zhu, B, 2019) |
| "Depression was induced via six weeks of CUMS in male ICR mice, and drug therapy was given simultaneously for the last three weeks." | 5.62 | Baicalin ameliorates chronic unpredictable mild stress-induced depression through the BDNF/ERK/CREB signaling pathway. ( Cao, Z; Chen, Y; Chu, L; Jia, Z; Lu, Y; Pei, L; Yang, J; Zhang, J; Zhang, S; Zhao, J, 2021) |
| " The aim of the study is to verify whether LAC can have an antidepressant action in a population of elderly patients with dysthymic disorder in comparison with a traditional antidepressant such as fluoxetine." | 5.17 | L-Acetylcarnitine in dysthymic disorder in elderly patients: a double-blind, multicenter, controlled randomized study vs. fluoxetine. ( Bersani, FS; Bersani, G; Colletti, C; Denaro, A; Koverech, A; Liberati, D; Meco, G; Nicolai, R, 2013) |
| "Radiation therapy and concomitant temozolomide chemotherapy are commonly used in treatment of brain tumors, but they may also result in behavioral impairments such as anxiety and cognitive deficit." | 3.91 | Fluoxetine reverses brain radiation and temozolomide-induced anxiety and spatial learning and memory defect in mice. ( Chai, D; Gan, H; Wu, S; Zhang, Q; Zhu, B, 2019) |
| "Depression is a disabling psychiatric disorder affecting millions of people all around the world." | 1.62 | SAHA Improves Depressive Symptoms, Cognitive Impairment and Oxidative Stress: Rise of a New Antidepressant Class. ( Amini-Khoei, H; Dehpour, AR; Ershadi, ASB; Hosseini, MJ, 2021) |
| "Cognitive decline is a common clinical symptom in Parkinson's disease (PD) patients." | 1.62 | Fluoxetine tunes the abnormal hippocampal oscillations in association with cognitive impairments in 6-OHDA lesioned rats. ( Feng, H; Liu, W; Zhang, R; Zhu, H, 2021) |
| "Depression was induced via six weeks of CUMS in male ICR mice, and drug therapy was given simultaneously for the last three weeks." | 1.62 | Baicalin ameliorates chronic unpredictable mild stress-induced depression through the BDNF/ERK/CREB signaling pathway. ( Cao, Z; Chen, Y; Chu, L; Jia, Z; Lu, Y; Pei, L; Yang, J; Zhang, J; Zhang, S; Zhao, J, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (40.00) | 24.3611 |
| 2020's | 6 (60.00) | 2.80 |
| Authors | Studies |
|---|---|
| Almeida, OP | 1 |
| Hankey, GJ | 1 |
| Ford, A | 1 |
| Etherton-Beer, C | 1 |
| Flicker, L | 1 |
| Hackett, ML | 1 |
| Laureano-Melo, R | 1 |
| Dos-Santos, RC | 1 |
| da Conceição, RR | 1 |
| de Souza, JS | 1 |
| da Silva Lau, R | 1 |
| da Silva Souza Silva, S | 1 |
| Marinho, BG | 1 |
| Giannocco, G | 1 |
| Ahmed, RG | 1 |
| da Silva Côrtes, W | 1 |
| Ershadi, ASB | 1 |
| Amini-Khoei, H | 1 |
| Hosseini, MJ | 1 |
| Dehpour, AR | 1 |
| Liu, W | 1 |
| Zhang, R | 1 |
| Feng, H | 1 |
| Zhu, H | 1 |
| Viktorisson, A | 1 |
| Andersson, EM | 1 |
| Lundström, E | 1 |
| Sunnerhagen, KS | 1 |
| Jia, Z | 1 |
| Yang, J | 1 |
| Cao, Z | 1 |
| Zhao, J | 1 |
| Zhang, J | 1 |
| Lu, Y | 1 |
| Chu, L | 1 |
| Zhang, S | 1 |
| Chen, Y | 1 |
| Pei, L | 1 |
| Gan, H | 1 |
| Zhang, Q | 1 |
| Zhu, B | 1 |
| Wu, S | 1 |
| Chai, D | 1 |
| Zhou, CN | 1 |
| Chao, FL | 1 |
| Zhang, Y | 1 |
| Jiang, L | 1 |
| Zhang, L | 1 |
| Fan, JH | 1 |
| Wu, YX | 1 |
| Dou, XY | 1 |
| Tang, Y | 1 |
| Gunlicks-Stoessel, M | 1 |
| Eckshtain, D | 1 |
| Lee, S | 1 |
| Reigstad, K | 1 |
| Mufson, L | 1 |
| Weisz, J | 1 |
| Bersani, G | 1 |
| Meco, G | 1 |
| Denaro, A | 1 |
| Liberati, D | 1 |
| Colletti, C | 1 |
| Nicolai, R | 1 |
| Bersani, FS | 1 |
| Koverech, A | 1 |
4 trials available for fluoxetine and Cognitive Dysfunction
| Article | Year |
|---|---|
Cognitive Impairment After Stroke and Treatment With Fluoxetine: A Planned Analysis of the AFFINITY Randomized Controlled Trial.
Topics: Cognitive Dysfunction; Double-Blind Method; Fluoxetine; Humans; Selective Serotonin Reuptake Inhibit | 2022 |
Levels of physical activity before and after stroke in relation to early cognitive function.
Topics: Aged; Cognition; Cognitive Dysfunction; Exercise; Female; Fluoxetine; Humans; Longitudinal Studies; | 2021 |
Latent Profiles of Cognitive and Interpersonal Risk Factors for Adolescent Depression and Implications for Personalized Treatment.
Topics: Adolescent; Antidepressive Agents, Second-Generation; Child; Cognitive Behavioral Therapy; Cognitive | 2019 |
L-Acetylcarnitine in dysthymic disorder in elderly patients: a double-blind, multicenter, controlled randomized study vs. fluoxetine.
Topics: Acetylcarnitine; Aged; Aged, 80 and over; Aging; Antidepressive Agents; Cognitive Dysfunction; Diagn | 2013 |
6 other studies available for fluoxetine and Cognitive Dysfunction
| Article | Year |
|---|---|
Perinatal fluoxetine treatment promotes long-term behavioral changes in adult mice.
Topics: Animals; Animals, Newborn; Anxiety; Cognitive Dysfunction; Female; Fluoxetine; Hippocampus; Male; Mi | 2020 |
SAHA Improves Depressive Symptoms, Cognitive Impairment and Oxidative Stress: Rise of a New Antidepressant Class.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Cognitive Dysfunction; Depression; Female; Fluoxet | 2021 |
Fluoxetine tunes the abnormal hippocampal oscillations in association with cognitive impairments in 6-OHDA lesioned rats.
Topics: Adrenergic Agents; Animals; Behavior, Animal; Brain Waves; Cognitive Dysfunction; Disease Models, An | 2021 |
Baicalin ameliorates chronic unpredictable mild stress-induced depression through the BDNF/ERK/CREB signaling pathway.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Brain-Derived Neurotrophic Factor; Cognitive Dysfu | 2021 |
Fluoxetine reverses brain radiation and temozolomide-induced anxiety and spatial learning and memory defect in mice.
Topics: Animals; Anti-Anxiety Agents; Antineoplastic Agents, Alkylating; Anxiety; Brain Diseases; Chemoradio | 2019 |
Fluoxetine delays the cognitive function decline and synaptic changes in a transgenic mouse model of early Alzheimer's disease.
Topics: Alzheimer Disease; Animals; Cognitive Dysfunction; Dendritic Spines; Disease Models, Animal; Fluoxet | 2019 |